Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-29T17:38:12.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a recruitment status update ('No longer looking for participants'), adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), and updates the Intervention/Treatment heading formatting along with the revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:40:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a Related topics section with MedlinePlus Genetics and updated the page revision from v3.5.4 to v3.5.5, indicating a minor metadata refresh.
    Difference
    0.2%
    Check dated 2026-06-08T03:43:47.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Removed the disease label 'Multiple Myeloma' under Conditions, the 'related topics' section header, and the 'MedlinePlus Genetics' resource link. This changes how the study's focus is presented and where users can access background health information on the page.
    Difference
    0.2%
    Check dated 2026-05-24T14:25:30.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-05-17T09:24:38.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now explicitly lists 'Multiple myeloma' as the condition. It adds a 'related topics' section with MedlinePlus Genetics as a linked resource.
    Difference
    0.2%
    Check dated 2026-05-03T00:57:05.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.